Clinical Trials
19 trialsNCT07606287 2026-05-26
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT01552434 2026-05-15
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT04996875 2026-05-05
APEX
Cogent Biosciences, Inc.
Phase 2 Recruiting
NCT03737734 2026-04-06
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
Alpha Tau Medical LTD.
Phase NA Active not recruiting
NCT07062003 2025-12-09
Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors, MBRT1 Trial
Mayo Clinic
Phase NA Recruiting
NCT03886181 2025-12-08
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)
Alpha Tau Medical LTD.
Phase NA Terminated
NCT03889899 2025-12-02
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT04540588 2025-12-02
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
Alpha Tau Medical LTD.
Phase NA Completed
NCT06939855 2025-11-19
QL1706 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Recruiting
NCT02285439 2025-10-07
Study of MEK162 for Children With Low-Grade Gliomas
Children's Hospital Los Angeles
Phase 1/2 Completed
NCT04534127 2025-02-07
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT03867188 2023-03-22
Liposomal Bupivacaine (Exparel) in Sarcomas
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Terminated
NCT03159585 2020-01-22
To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors
Zhujiang Hospital
Phase 1 Completed
NCT01965002 2018-05-23
Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors
Stanford University
Phase NA Terminated
NCT02066675 2018-04-11
TR1US
Italian Sarcoma Group
Phase 2 Completed
NCT02441972 2017-03-10
Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Wuxi No. 4 People's Hospital
Phase 1 Unknown
NCT02895633 2016-09-12
TUMOSTEO
Central Hospital, Nancy, France
Phase NA Unknown
NCT01017978 2015-12-04
Quantitative MR Biomarkers for Sarcoma Treatment
University of Michigan
Phase NA Completed
NCT01630239 2015-05-05
MR-Guided Laser Ablation of Hepatic Tumors
Mayo Clinic
Phase EARLY_PHASE1 Completed